ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,840.93
      1.64%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Rxi Pharmaceuticals Corp. (MM) (RXII)

      7. Rxi Pharmaceuticals Corp. (MM) (RXII) News

      RXII

      RXI Pharmaceuticals Corporation (RXII)

      Rxi Pharmaceuticals Corp. (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:RXII
      DateTimeSourceHeadlineSymbolCompany
      04/13/20186:04AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      04/11/20184:33PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      04/11/201812:56PMPR Newswire (US)RXi Pharmaceuticals Announces Closing of $4.9 Million Registered Direct OfferingNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      04/11/201811:14AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      04/11/20187:48AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      04/09/20182:04PMPR Newswire (US)RXi Pharmaceuticals Announces $4.9 Million Registered Direct Offering Priced At-the-MarketNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      04/09/20186:02AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      04/04/20187:05AMPR Newswire (US)RXi Pharmaceuticals to Present an Update on its Clinical and Cosmetic Dermatology Programs at the International Investigative...NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      03/29/20185:23PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      03/29/20185:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      03/27/201810:12AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      03/26/20184:54PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      03/26/20184:52PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      03/26/20184:48PMEdgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      03/26/20184:41PMEdgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      03/26/20184:40PMPR Newswire (US)RXi Pharmaceuticals Reports Fourth Quarter and Year End 2017 Financial Results and Recent Corporate HighlightsNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      03/26/20184:37PMEdgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      03/26/20184:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      03/21/20181:00PMPR Newswire (US)RXi Pharmaceuticals to Webcast Fourth Quarter and Year End 2017 Financial Results on Monday, March 26, 2018NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      03/20/20187:05AMPR Newswire (US)RXi Pharmaceuticals Selected to Present at the Landmark Venture ForumNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      02/12/20185:03PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      02/05/20187:05AMPR Newswire (US)RXi Pharmaceuticals to Present at the BIO CEO and Investor ConferenceNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      01/24/20182:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      01/24/201812:06PMPR Newswire (US)RXi Pharmaceuticals Regains Compliance with NASDAQ Listing RequirementsNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      01/17/20187:05AMPR Newswire (US)RXi Pharmaceuticals to Present at Immuno-Oncology Frontiers World ConferenceNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      01/16/20187:05AMPR Newswire (US)RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate GrowthNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      01/05/20185:22PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      01/05/201812:45PMPR Newswire (US)RXi Pharmaceuticals Announces Reverse Stock SplitNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      12/29/20177:05AMPR Newswire (US)RXi Pharmaceuticals to Present at the 10th Annual Biotech Showcase ConferenceNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
      12/18/20177:05AMPR Newswire (US)RXi Pharmaceuticals Announces Positive Results from Phase 2 Trial with RXI-109 for Dermal ScarringNASDAQ:RXIIRxi Pharmaceuticals Corp. (MM)
       Showing the most relevant articles for your search:NASDAQ:RXII